[1]
F. Scolari, “Can Tolvaptan (OTSUKA) be a useful drug for patients with ADPKD? How could future treatment of patients change with Adpkd?”, G Clin Nefrol Dial, vol. 24, no. 4, pp. 89–91, Jan. 2018.